Promoting and facilitating strategies to improve cardiovascular health worldwide

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



Church-based intervention significantly improves older African Americans’ eating habits

Posted on February 21, 2020

A church-based intervention significantly improved the diets of middle-aged and older African Americans, according to longitudinal trial results published in the American... more

FDA approves bempedoic acid for LDL lowering in high-risk populations

Posted on February 21, 2020

The FDA has approved bempedoic acid for reducing LDL as an adjunct to diet and maximally tolerated statin therapy in patients with... more

Mechanical clot removal alone may be as effective as joint use with thrombolysis in stroke

Posted on February 21, 2020

Among patients with acute stroke and large-vessel occlusion, adding IV thrombolysis to endovascular therapy may not be necessary, according to findings presented... more

Lower target LDL after stroke prevents 25% of events at 5 years

Posted on February 21, 2020

During the 5 years after a stroke, targeting LDL of less than 70 mg/dL prevented more than one-quarter of major CV events,... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  •  Hector Ventura


    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  •  Jack Tan


    Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis (more…) more

  •  Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  •  Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more